Evoke Pharma Inc (EVOK)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

420 STEVENS AVENUE SOLANA BEACH, CA 92075

Evoke Pharma, Inc. develops, manufactures, and markets pharmaceutical products. The company offers a gastrointestinal product for the treatment of patients with diabetic gastroparesis for patients suffering from gastrointestinal diseases and disorders.

Data as of 2021-05-08 11:23:54 -0400
Market Cap51.148 Million Shares Outstanding32.372 Million Avg 30-day Volume257.196 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.13097 52-week High/Low6.06 / 1.28 Next Earnings Date2021-05-11 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from EVOK instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 32 28 14.29% 6 (0.36%) 6 (0.37%) 0.0%
13F shares: 2.616 Million 1.863 Million 40.41% 960 Thousand 314.613 Thousand 205.14%
% Ownership 9.9124 7.0594 40.41% 3.6377 1.1922 205.12%
New Positions: 7 10 -30.0% 1 4 -75.0%
Increased Positions 10 4 150.0% 5 1 400.0%
Closed Positions 3 3 0.0% 1 1 0.0%
Reduced Positions 5 4 25.0% 1
Total Calls 126.673 Thousand 184.956 Thousand -31.51% 81.5 Thousand 131.6 Thousand -38.07%
Total Puts 37.022 Thousand 21.957 Thousand 68.61% 1.12 Thousand 1.519 Thousand -26.27%
PUT/CALL Ratio 0.29 0.12 141.67% 0.01 0.01 0.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding EVOK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EVOK BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CARLSON MARILYN R. CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-27 2

GONYER DAVID A PRESIDENT AND CEO

  • Officer
  • Director
0 2021-01-27 4

D'ONOFRIO MATTHEW J EXEC VP, CHIEF BUS. OFFICER

  • Officer
0 2021-01-27 4

HILL MALCOLM R

  • Director
0 2020-05-27 1

BRADY TODD C

  • Director
0 2020-05-27 1

GARNER CAM L

  • Director
0 2020-05-27 1

RHOADS ANN D

  • Director
0 2020-05-27 1

WIDDER KENNETH J

  • Director
0 2020-05-27 1

LVP GP III, LLC

LATTERELL PATRICK F

LVP III ASSOCIATES, L.P.

LVP III PARTNERS LP

LVP LIFE SCIENCE VENTURES III L.P.

LVPMC, LLC

  • 10% Owner
2,088,579 2018-08-20 0

GLENN SCOTT L

  • Director
0 2018-04-26 0

DOMAIN PARTERS VII L P

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
No longer subject to file 2016-05-26 0

DP VII ASSOCIATES LP

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

HALAK BRIAN K

  • 10% Owner
No longer subject to file 2016-05-26 0

DP VII ASSOCIATES LP

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

SCHOEMAKER KATHLEEN K

HALAK BRIAN K

  • 10% Owner
17,947 2015-08-18 0

DOMAIN PARTERS VII L P

BLAIR JAMES C

DOVEY BRIAN H

TREU JESSE I

VITULLO NICOLE

SCHOEMAKER KATHLEEN K

HALAK BRIAN K

  • 10% Owner
1,052,328 2015-08-18 0

SHAH NIMESH

  • 10% Owner
5,250 2015-01-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EVOKE PHARMA INC EVOK 2021-05-10 22:15:04 UTC -5.8065 5.8565 500000
EVOKE PHARMA INC EVOK 2021-05-10 21:45:02 UTC -5.8065 5.8565 500000
EVOKE PHARMA INC EVOK 2021-05-10 21:15:02 UTC -5.8065 5.8565 500000
EVOKE PHARMA INC EVOK 2021-05-10 20:45:03 UTC -5.8955 5.9455 500000
EVOKE PHARMA INC EVOK 2021-05-10 20:15:03 UTC -5.8955 5.9455 500000
EVOKE PHARMA INC EVOK 2021-05-10 19:45:03 UTC -5.8955 5.9455 500000
EVOKE PHARMA INC EVOK 2021-05-10 19:15:03 UTC -5.8955 5.9455 500000
EVOKE PHARMA INC EVOK 2021-05-10 18:45:03 UTC -6.0563 6.1063 500000
EVOKE PHARMA INC EVOK 2021-05-10 18:15:03 UTC -6.0563 6.1063 500000
EVOKE PHARMA INC EVOK 2021-05-10 17:45:02 UTC -6.0563 6.1063 500000
EVOKE PHARMA INC EVOK 2021-05-10 17:15:03 UTC -6.0563 6.1063 500000
EVOKE PHARMA INC EVOK 2021-05-10 16:45:03 UTC -6.0563 6.1063 500000
EVOKE PHARMA INC EVOK 2021-05-10 16:15:03 UTC -6.0563 6.1063 500000
EVOKE PHARMA INC EVOK 2021-05-10 15:45:03 UTC -6.0563 6.1063 500000
EVOKE PHARMA INC EVOK 2021-05-10 15:15:03 UTC -6.0563 6.1063 500000
EVOKE PHARMA INC EVOK 2021-05-10 14:45:04 UTC -6.2254 6.2754 500000
EVOKE PHARMA INC EVOK 2021-05-10 14:15:04 UTC -6.2254 6.2754 500000
EVOKE PHARMA INC EVOK 2021-05-10 13:45:04 UTC -6.2254 6.2754 500000
EVOKE PHARMA INC EVOK 2021-05-10 13:15:03 UTC -6.2254 6.2754 500000
EVOKE PHARMA INC EVOK 2021-05-10 12:45:02 UTC -6.2254 6.2754 500000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund EVOK -400.0 shares, $-732.0 2021-03-31 N-PORT

Elevate your investments